Incannex Healthcare Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The number of shares of Common Stock repurchased by us under our share repurchase program and the average price paid per share for the three months ended March 31, 2026, are as follows:
| Period | (a) Total Number of Shares Repurchased | (b) Average Price Paid Per Share | (c) Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs | (d) Maximum Dollar Value of Shares that May Yet Be Repurchased Under the Plans or Programs |
|---|---|---|---|---|
| January 2026 (1/1/2026 - 1/31/2026) | 29,650 | 9.69 | 29,650 | 18,536,817 |
| February 2026 (2/1/2026 - 2/28/2026) | - | - | - | 18,536,817 |
| March 2026 (3/1/2026 - 3/31/2026) | 260,911 | 3.28 | 260,911 | 17,681,029 |
| Total(1) | 290,561 | 290,561 | 17,681,029 |
| (1) | In August 2025, our board of directors authorized a share repurchase program pursuant to which we may repurchase up to $20 million of our outstanding shares of Common Stock. The share repurchase program expires on August 30, 2026. Under the share repurchase program, the Company may repurchase shares from time to time in the open market, privately negotiated transactions, accelerated share repurchase arrangements, or other methods permitted under applicable securities laws, including in compliance with Rule 10b-18 of the Exchange Act. All purchases listed above were made in the open market at prevailing market prices. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.